BRIEF-Valeant says did not produce documents to Oversight Committee, cites attorney-client privilege

Thu Mar 10, 2016 12:43pm EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

March 10 (Reuters) - Valeant Pharmaceuticals International Inc:

* Valeant issues statement responding to the March 10th letter from the House Oversight Committee

* Says declined to produce documents to oversight committee covered by the attorney-client privilege

* Says preparing a log for Oversight Committee detailing what documents are being withheld under that privilege

* Says produced more than 78,000 pages of documents to House Oversight Committee

* "We have cooperated with the Committee's review from beginning and look forward to providing them with the log, pursuant to their request" Source text ( Further company coverage: